Nalin Ratnayeke

The paper shows that B-MYB/FOXM1 controls daughter cell fate by regulating mitotic E2F activity through timing of its activation during the cell cycle.

GIFT enables high-accuracy genotyping in single cells, revealing mutation-dependent hematopoietic responses in MPN patients.

In mouse pancreatic cancer models, p53, CDKN2A and SMAD4 programs converge on a rare Kras-mutant progenitor-like state whose niche KRAS inhibition collapses and p53 loss expands.

The paper shows YAP and mitogen signaling regulate the cyclin D1/p27 ratio during G1 phase, determining cell cycle entry or exit through receptor-mediated mechanisms and contact inhibition.